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Introduction
Anaplastic large cell lymphoma (ALCL) is a subgroup
of non-Hodgkin’s lymphoma first described by Stein
et al in 1985.1 It is characterized by large atypical lym-
phoid cells with pleomorphic and often horseshoe-
shaped nuclei and abundant cytoplasm, called hallmark
cells. These tumor cells show strong expression of
CD30 antigen.2 Only T cell or null-cell phenotypes are
included in ALCL. The B cell phenotype is excluded
and classified as anaplastic large cell variant of diffuse
large B cell lymphoma.3 The most common sites of
ALCL involvement are the lymph node, followed by
skin, bone and soft tissue.4
According to molecular and clinical criteria, there
are 3 categories of ALCLs: primary systemic ALK(+)
ALCL; primary systemic ALK(−) ALCL; and primary
cutaneous ALCL. Anaplastic lymphoma kinase (ALK)
expression is predominantly caused by the genetic
abnormality of t(2;5) translocation. The translocation
leads to the nucleophosmin (NPM) gene over 5q35
fusing with the ALK gene over 2p23 and results in
the formation of NPM-ALK fusing protein. ALK(+)
ALCL mostly occurs in the first 3 decades of life, with
male predominance. It has a better response to chemo-
therapy and better prognosis for survival, whereas
ALK(−) ALCL usually occurs in older patients and
has a comparably dismal clinical course.3
Primary gastric ALCLs are extremely rare.1,5–18
To our knowledge, only 22 cases have been reported
in the English literature, and none of them seemed to
be of the lymphohistiocytic variant, which is observed
mostly in the first 2 decades of life with initial presen-
tation of superficial lymphadenopathy.19 We herein
report a unique case of primary lymphohistiocytic vari-
ant ALCL of the stomach in an elderly patient.
Case Report
A 70-year-old female was referred to our hospital due to
epigastric pain, tarry stool, and body weight loss for half
a year after March 2004. Physical examination on 
admission showed neither cutaneous skin lesions nor
superficial lymphadenopathy. Hematologic examina-
tion results were as follows: white blood cell count,
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2,180/μL; hemoglobin, 7.9 g/dL; hematocrit, 37.8%;
platelet count, 11,900/μL; aspartate aminotransferase,
332 U/L; alanine aminotransferase, 96 U/L; lactate
dehydrogenase, 1,798 U/L; and alkaline phosphatase,
262 U/L. Laboratory data of electrolytes and renal
function test were within normal limits. Serologic tests
were negative for both the human T cell leukemia virus
(HTLV-1) and Epstein-Barr virus (EBV).
An upper gastrointestinal endoscopy was performed,
which showed an ulcerative tumor with adjacent super-
ficial ulcer and thickening of the stomach wall, sug-
gesting a malignant neoplasm. Computed tomography
showed mild thickening of the stomach wall with
perigastric lymphadenopathy and multiple tumor nod-
ules in bilateral lobes of the liver. Due to uncontrolled
upper gastrointestinal bleeding, emergent total gas-
trectomy with regional lymph node dissection and liver
biopsy were performed.
The resected specimen of the stomach showed an
ulcerative tumor, Bormann type II, 2 × 2 cm, located
in the middle third of the posterior wall, protruding
to the lesser sac with serosal invasion. There was also a
superficial ulcer adjacent to the main tumor. Marked
thickening of the gastric wall from mid-body to antrum,
enlarged perigastric lymph nodes, up to 3 × 2 × 1 cm,
and peritoneal tumor seeding over the greater curva-
ture site and mesentery were found. The specimen of
the liver measured 1.3 × 0.7 × 0.5 cm.
Histologically, the gastric mucosa showed an
ulcerative lesion covered with a layer of inflammatory
exudates (Figure 1), and the whole layer of the gastric
wall was diffusely infiltrated with discohesive medium-
to large-sized atypical cells admixed with a large num-
ber of reactive histiocytes, a few lymphocytes and
plasma cells. These histiocytes had eccentric, round,
dense nuclei and acidophilic cytoplasm reminiscent 
of plasma cells. The neoplastic cells displayed round
to oval, large, irregular and sometimes horseshoe- or
kidney-shaped nuclei and single or multiple distinct
nucleoli with a mild to moderate amount of cytoplasm
(Figure 2). Clustering of the neoplastic cells around
the blood vessels was also observed. Immunohisto-
chemistry showed that the tumor cells stained posi-
tively for CD30 (Figure 3), LCA, CD45RO (UCHL1)
and CD3 (Figure 4); negatively for CD20 (L26),
CD68, myeloperoxidase (MPO), lysozyme, epithelial
membrane antigen (EMA), CD15, CD79a, CD138,
PAX5 and ALK. Moreover, the histiocytes showed
moderate cytoplasmic staining for CD68 (Figure 5)
and lysozyme. The histologic pictures and immunohis-
tochemical characteristics of these tumors in the liver,
perigastric lymph nodes and peritoneum were similar
to those of the stomach. Based on the morphologic
Figure 1. Gastric mucosa shows an ulcerative lesion with neo-
plastic cell infiltration throughout the whole layer of stomach
(hematoxylin & eosin, 40×).
Figure 2. Neoplastic cells show round to oval, large irregular and
occasionally kidney-shaped nuclei and single or multiple nucleoli
with a mild to moderate amount of cytoplasm (hematoxylin &
eosin, 400×).
Figure 3. CD30 staining demonstrates positive reactivity on the
membrane of lymphoma cells (400×).
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and immunohistochemical findings, a diagnosis of
primary gastric ALCL of lymphohistiocytic variant
with involvement of perigastric lymph nodes, peri-
toneum and liver metastasis was made.
The other workup showed normal chest X-ray and
gallium bone scan. The pancreas, spleen and kidney
were unremarkable on ultrasonography and bone mar-
row biopsy was normal. The patient then received
postoperative chemotherapy with the CHOP regimen
(cyclophosphamide, adriamycin, oncovin, predniso-
lone). She was still alive without evidence of tumor
nodules in the liver and without intra-abdominal 
lymphadenopathy after 17 months of follow-up.
Discussion
ALCL can be subclassified into common (classic) type
(70%), lymphohistiocytic variant (10%), small cell vari-
ant (5–10%) and other rare patterns. However, all
cases of ALCL have a variable number of cells with
eccentrically placed horseshoe- or kidney-shaped nuclei,
often with an eosinophilic region near the nucleus, the
so-called hallmark cells.2,3 Clinically, most cases of lym-
phohistiocytic ALCL occur during the first 2 decades
of life, at a younger age than the common type of
ALCL, and usually present with superficial lymphade-
nopathy and systemic symptoms.19,20 Histologically,
lymphohistiocytic ALCL exhibits tumor cells admixed
with abundant reactive histiocytes. The neoplastic cells
are usually smaller than those of the common type. The
reactive histiocytes have prominent acidophilic cyto-
plasm and an eccentric, dense nucleus and sometimes
contain phagocytosed erythrocytes that may mask the
neoplastic cells.3,19,20 Perivascular cuffing of the tumor
cells, which can be reinforced with immunostaining of
CD30 or ALK, is a dominant feature and diagnostic
hint to this variant of ALCL.2 The large anaplastic cells
of lymphohistiocytic ALCL can express CD30 and are
usually immunoreactive for EMA and ALK, but are
nonreactive for histiocytic markers.3 In contrast to
the common variant of ALCL, it shows a comparably
favorable response to chemotherapy.19,20
The main differential diagnosis includes undiffer-
entiated carcinoma, Hodgkin’s lymphoma, and his-
tiocytic sarcoma.3,12,19,21 Primary gastric ALCL may
sometimes be misdiagnosed as gastric carcinoma from
radiologic and endoscopic findings, microscopic pic-
tures or immunohistochemical properties.12,14,22–24 The
endoscopic and imaging findings of gastric ALCLs
vary. They may show a protruding mass with ulcera-
tion or an ulcerative tumor. Under such circumstances,
it is often difficult to distinguish lymphoma from car-
cinoma. However, they may occasionally present as a
submucosal tumor with/without superficial ulcera-
tion, which is quite different from conventional gas-
tric carcifnoma.22 Microscopic morphology can be
misinterpreted as undifferentiated carcinoma because
the tumor cells may show cohesive change, especially
in the affected lymph nodes.23 Immunohistochemi-
cally, the neoplastic cells of ALCL may occasionally
express cytokeratin and epithelial membrane antigen,
whereas LCA (CD45) expression is not always the
rule.23,25 Therefore, performing immunohistochem-
istry analyses for cytokeratin, LCA and CD30 antigen
simultaneously is suggested when poorly differentiated
tumors are encountered.12
There may be morphologic overlap between ALCL
and Hodgkin’s lymphoma. Classical Hodgkin’s lym-
phoma rich in neoplastic cells sometimes has morpho-
logic features indistinguishable from those of ALCL.
However, the frequent expression of B cell-specific
activation protein BSAP (PAX-5) and essentially no
Figure 5. Reactive histiocytes show cytoplasmic staining with
CD68 antibody (400×).
Figure 4. Large-sized neoplastic cells are strongly positive for
CD3 and predominate around blood vessels (200×).
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Table 1. Clinicopathologic and immunohistochemical features of previously reported cases of gastric anaplastic large cell lymphomas
Case Authors Year Age/Sex Type LN ALK EMA Tx Follow-up survival
1 Stein et al 1985 17/M Null N/A N/A N/A N/A N/A
2 Moubayed et al 1987 18/M T + N/A N/A S/C A3 yr
3 Kanavaros et al 1988 58/M T + N/A − S/C A12 mo
4 Chan et al 1989 79/F T + N/A + S DOD 6 wk
5 Paulli et al 1994 75/F Null + N/A N/A C A20 mo
6 Paulli et al 1994 35/M Null + N/A N/A S/C DOD 23 mo
7 Paulli et al 1994 82/F T + N/A N/A None DOD 45 d
8 Yatabe et al 1994 59/M T − N/A − S/C DOD 10 mo
9 Takimoto et al 1994 29/M T + N/A − S/C DOD 31 mo
10 Biernat et al 1994 37/F T N/A N/A + N/A N/A
11 Mori et al 1994 31/M Null − N/A − S A96 mo
12 Mori et al 1994 63/M Null − N/A − S A24 mo
13 Griesser et al 1994 48/M T N/A N/A (+) N/A N/A
14 Griesser et al 1994 36/M T N/A N/A + N/A N/A
15 Griesser et al 1994 79/M T N/A N/A − N/A N/A
16 Griesser et al 1994 80/M T N/A N/A − N/A N/A
17 Griesser et al 1994 79/F T N/A N/A + N/A N/A
18 Nakamura et al 1998 73/F T + N/A − S D7 wk
19 Kahaleh et al 2002 45/M T + − N/A S/C A24 mo
20 Lee et al 2003 68/F Null N/A + N/A N/A N/A
21 Iwamizu-Watanabe 2004 72/F Null N/A + + S A84 mo
et al
22 Song et al 2005 50/F T + − − S/C A7 mo
LN = lymph node; ALK = anaplastic lymphoma kinase; EMA = epithelial membrane antigen; Tx = treatment; T = T cell; N/A = not available; (+) = only a few positive
tumor cells; S = surgery; C = chemotherapy; A = alive; DOD = died of disease; D = died.
reactivity for ALK may favor a tumor cell-rich Hodgkin’s
lymphoma rather than ALCL.2,3
Histiocytic sarcoma is a malignant neoplasm show-
ing morphologic and immunologic features similar to
those of mature histiocytes. Immunohistochemically,
the neoplastic cells can express macrophage markers
(lysozyme, CD68), but are nonreactive for CD30,
EMA, HMB45 and keratin.21
Primary gastric ALCLs are extremely rare. To the
best of our knowledge, only 22 cases have been re-
ported so far in the English literature, as summarized
in Table 1. These patients ranged in age from 17 years
to 82 years, with a mean age of 55 years; there was a
slight male predominance (F/M ratio: 9/13). Fifteen
cases displayed T cell phenotype and 7 cases showed
null cell type. Ten (77%) of 13 patients showed re-
gional lymph node involvement. Histologically, the
reactive cells included lymphocytes, histiocytes, plasma
cells, neutrophils, and eosinophils. However, none of
the cases seemed to feature numerous reactive histio-
cytes. Most patients underwent surgery with or with-
out subsequent chemotherapy. Only 1 patient was
treated with chemotherapy alone. Gastric ALCL has an
extremely poor prognosis. Nakamura et al reported that
analysis of 12 patients with gastric ALCL (including 
1 B cell phenotype) revealed an estimated 5-year sur-
vival rate of 13%,14 whereas a study involving a large
series of ALCL patients showed that the 5-year overall
survival rate of ALK(+) versus ALK(−) ALCL was 93%
versus 37%.26
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